Citation: Pa. Kupelian et Tr. Willoughby, Short-course, intensity-modulated radiotherapy for localized prostate cancer, CANCER J, 7(5), 2001, pp. 421-426
Authors:
Kupelian, PA
Reddy, CA
Klein, EA
Willoughby, TR
Citation: Pa. Kupelian et al., Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life, INT J RAD O, 51(4), 2001, pp. 988-993
Authors:
Kupelian, PA
Buchsbaum, JC
Reddy, CA
Klein, EA
Citation: Pa. Kupelian et al., Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason <= 6, and pretreatment prostate-specific antigen <= 10), INT J RAD O, 50(3), 2001, pp. 621-625
Authors:
Kattan, MW
Zelefsky, MJ
Kupelian, PA
Scardino, PT
Fuks, Z
Leibel, SA
Citation: Mw. Kattan et al., Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer, J CL ONCOL, 18(19), 2000, pp. 3352-3359
Authors:
Kupelian, PA
Mohan, DS
Lyons, J
Klein, EA
Reddy, CA
Citation: Pa. Kupelian et al., Higher than standard radiation doses (>= 72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer, INT J RAD O, 46(3), 2000, pp. 567-574
Citation: Ds. Mohan et al., Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland, INT J RAD O, 46(3), 2000, pp. 575-580
Authors:
Fergany, A
Kupelian, PA
Levin, HS
Zippe, CD
Reddy, C
Klein, EA
Citation: A. Fergany et al., No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients, UROLOGY, 56(1), 2000, pp. 92-95
Citation: Jh. Suh et al., Results of linear accelerator-based stereotactic radiosurgery for recurrent and newly diagnosed acoustic neuromas, INT J CANC, 90(3), 2000, pp. 145-151
Authors:
Paris, PL
Witte, JS
Kupelian, PA
Levin, H
Klein, EA
Catalona, WJ
Casey, G
Citation: Pl. Paris et al., Identification and pine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancersusceptibility locus, CANCER RES, 60(13), 2000, pp. 3645-3649
Authors:
Chidel, MA
Suh, JH
Greskovich, JF
Kupelian, PA
Barnett, GH
Citation: Ma. Chidel et al., Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis., RADIAT ON I, 7(5), 1999, pp. 313-319
Authors:
Paris, PL
Kupelian, PA
Hall, JM
Williams, TL
Levin, H
Klein, EA
Casey, G
Witte, JS
Citation: Pl. Paris et al., Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients, CANC EPID B, 8(10), 1999, pp. 901-905
Authors:
Jhaveri, FM
Klein, EA
Kupelian, PA
Zippe, C
Levin, HS
Citation: Fm. Jhaveri et al., Declining rates of extracapsular extension after radical prostatectomy: Evidence for continued stage migration, J CL ONCOL, 17(10), 1999, pp. 3167-3172
Authors:
Jhaveri, FM
Zippe, CD
Klein, EA
Kupelian, PA
Citation: Fm. Jhaveri et al., Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results, UROLOGY, 54(5), 1999, pp. 884-890
Authors:
Chidel, MA
Rice, TW
Adelstein, DJ
Kupelian, PA
Suh, JH
Becker, M
Citation: Ma. Chidel et al., Resectable esophageal carcinoma: Local control with neoadjuvant chemotherapy and radiation therapy, RADIOLOGY, 213(1), 1999, pp. 67-72
Authors:
Sohayda, CJ
Kupelian, PA
Altsman, KA
Klein, EA
Citation: Cj. Sohayda et al., Race as an independent predictor of outcome after treatment for localized prostate cancer, J UROL, 162(4), 1999, pp. 1331-1336
Citation: Pa. Kupelian et al., Biological aggressiveness of hereditary prostate cancer: Long-term evaluation following radical prostatectomy - G. S. Bova, A. W. Partin, S. D. Isaacs, B. S. Carter, T. L. Beaty, W. B. Isaacs and P. C. Walsh - J. Urol., 160 : 660-663, 1998, J UROL, 161(5), 1999, pp. 1585-1586
Citation: Ds. Mohan et al., Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution, INT J RAD O, 42(5), 1998, pp. 981-987